Showing 1 - 4 of 4
Persistent link: https://www.econbiz.de/10002463348
Persistent link: https://www.econbiz.de/10001722217
This WTO working paper studies availability and affordability of new and innovative pharmaceuticals in a post-TRIPS era. The WTO's TRIPS Agreement (TRIPS) makes it obligatory for WTO members − except least-developed country members (LDCs) - to provide pharmaceutical product patents with a...
Persistent link: https://www.econbiz.de/10011992779
This paper examines access to new and innovative pharmaceuticals in a post-TRIPS era. The WTO’s TRIPS Agreement (TRIPS) makes it obligatory for WTO members – except least-developed country members (LDCs) - to provide pharmaceutical product patents with a 20-year protection term. Developing...
Persistent link: https://www.econbiz.de/10014105991